Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
about
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaCloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumorA new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasReflections upon human cancer immune responsiveness to T cell-based therapyIdentification of an alternate splice form of tapasin in human melanoma.Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyTumor antigens and tumor vaccines: peptides as immunogens.Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansionImmune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.Peptide vaccines for cancer.Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptideT-cell antigens in cancerGene therapy for carcinoma of the breast.Human stomach carcinoma-specific T cells derived from the tumour-draining lymph nodes.The immunologic aspects of poxvirus oncolytic therapyDetection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLAThe tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crestQuantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.T cell responses to ovarian tumor vaccines: identification and significance for future immunotherapy.More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.Autologous tumor rejection in humans: trimming the myths.Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patientsT-cell recognition of human melanoma antigensLocus-specific analysis of human leukocyte antigen class I expression in melanoma cell linesAttempts to optimize active specific immunotherapy for melanoma.Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.T-cell clones that react against autologous human tumors.The GP2 peptide: a HER2/neu-based breast cancer vaccine.The delicate balance of melanoma immunotherapy.Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes.Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001.
P2860
Q24307739-90412E01-019D-4015-AF56-1402CF09C1E2Q24312048-90FECE4B-9E4C-4832-8D90-4623F62DE81BQ24679739-26747A8F-9B1D-49F3-987B-523613C054ABQ27004674-FF678AA3-9D41-4704-B01B-90226649E22DQ30156803-BBB7DB37-D15F-4B84-807F-F6DB14B1097BQ30305530-1F6F030C-3DD1-43D9-B0F2-5DC5AD6E01D8Q30469630-87304F69-87B1-4A1F-A7F5-20FF4047CAFCQ33579883-76664322-E37A-4B97-9BD5-675E19360941Q33827463-7EE5BD50-9AD6-4E54-8780-3FA01EA6E6D8Q33894139-94139E2E-65AA-46E6-B2AA-591AF269F2A2Q34353878-E1F626CE-D103-4032-9B5A-189FBF4EB974Q34568992-56C55EC7-AA3E-48B0-BA5A-3AABEE477EF0Q34765735-CA3764BF-4FC3-4C52-9D25-9A88ECA909A3Q35179337-987FD454-70FD-4392-BAC8-48F436C6CC62Q35609061-59A2420C-D577-4D16-B82C-A0A62683886CQ36080640-7A2D08CD-B0B3-429B-960C-A31431F45A27Q36115128-80F31E69-7DCD-47CC-B16D-123B4BBBCA85Q36238343-14745D4C-0F87-4578-B1B2-9969AA59CF21Q36362111-386A89D5-AB44-43B6-95B2-35790796C8A4Q36363449-82570730-BFAF-449D-AA2A-7C01489D4690Q36375095-36CE0680-8637-4473-BEA2-FF5CF4A737E7Q36470250-132B28AF-6609-4BBA-9B57-B2E322E86B23Q36470734-6B3D9359-344A-4C2C-AAAE-120E01169C1EQ36542248-20C8C82B-E9AA-415A-B42A-FD71BE2916EAQ36568993-DBC362BD-0A9B-4B7C-B17F-09FE4EE1D86BQ36569014-47C4C1F9-96BC-4618-9B41-32F011258298Q36645793-387E5695-7DBB-4998-83AE-E0EEEFF40EFAQ36914400-AA2EB9CD-6CA5-4EDC-974F-442B3B2DF9BEQ36922798-D80F7941-1F9B-4BA2-92CF-B321C22AA357Q36930081-43FA3C20-2B33-4771-8067-74B4CA58A46BQ37324783-D12D0BCC-C812-4F70-B802-DE5E3B27F4F2Q37383437-C82571AC-EB66-4641-ABE4-A412ADCF39D5Q37609599-D701C9AF-3B76-4F5B-81F7-4C335740FAB9Q37763156-114CCB25-A631-447A-9E80-CDC0A707A696Q37861039-8D415B79-52CD-4C39-BBE3-229FEFAE3658Q37996354-BF0B7C46-C645-4EC3-9A0E-58C3A83FB5ADQ38288116-31C79CDB-D965-4856-BC50-A7346F8C5673Q38790788-7E9ACF27-812E-4143-AD7E-4D77AC30703EQ39712402-F5F807E4-DC4A-4C50-95DF-449B98C84455Q40129912-DDA841AF-17A4-4445-BC13-C6F7EC259EFA
P2860
Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Lysis of human melanoma cells ...... for three different antigens.
@ast
Lysis of human melanoma cells ...... for three different antigens.
@en
type
label
Lysis of human melanoma cells ...... for three different antigens.
@ast
Lysis of human melanoma cells ...... for three different antigens.
@en
prefLabel
Lysis of human melanoma cells ...... for three different antigens.
@ast
Lysis of human melanoma cells ...... for three different antigens.
@en
P2093
P2860
P356
P1476
Lysis of human melanoma cells ...... for three different antigens.
@en
P2093
P2860
P304
P356
10.1084/JEM.170.3.797
P407
P577
1989-09-01T00:00:00Z